Chinese Journal of Organic Chemistry ›› 2020, Vol. 40 ›› Issue (9): 2804-2810.DOI: 10.6023/cjoc202005081 Previous Articles     Next Articles

含丙烯酰胺结构的喹唑啉衍生物的合成及抗肿瘤活性研究

张路野a,b, 张洋a,b, 汪正捷a,b, 王涛a,b, 李二冬a,b, 刘丽敏a,b, 刘秀娟a,b, 郑甲信a,b, 可钰a,b, 单丽红a,d, 刘宏民a,b,c,d, 张秋荣a,b,d   

  1. a 郑州大学药学院 郑州 45000;
    b 新药创制与药物安全性评价河南省协同创新中心 郑州 450001;
    c 省部共建食管癌防治国家重点实验室 郑州 450052;
    d 教育部药物制备关键技术重点实验室 郑州 450001
  • 收稿日期:2020-05-28 修回日期:2020-06-17 发布日期:2020-07-01
  • 通讯作者: 张秋荣, 单丽红, 刘宏民 E-mail:zqr409@yeah.net;shlh@zzu.edu.cn;liuhm@zzu.edu.cn
  • 基金资助:
    国家自然科学基金(No.U1904163)、省部共建食管癌防治国家重点实验室开放基金(No.K2020000X)资助项目.

Synthesis and Antitumor Activity of Novel Quinazoline Derivatives Containing Acrylamide

Zhang Luyea,b, Zhang Yanga,b, Wang Zhengjiea,b, Wang Taoa,b, Li Erdonga,b, Liu Limina,b, Liu Xiujuana,b, Zheng Jiaxina,b, Ke Yua,b, Shan Lihonga,d, Liu Hongmina,b,c,d, Zhang Qiuronga,b,d   

  1. a School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001;
    b Collaborative Innovation Center of New Drug Research and Safety Evaluation of Henan Province, Zhengzhou 450001;
    c State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou 450052;
    d Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, Zhengzhou 450001
  • Received:2020-05-28 Revised:2020-06-17 Published:2020-07-01
  • Supported by:
    Project supported by the National Natural Science Foundation of China (No. U1904163), and the Opening Fund from State Key Laboratory of Esophageal Cancer Prevention & Treatment (No. K2020000X).

In order to find efficient and low toxicity anti-tumor drugs, a series of novel quinazoline derivatives containing N-(3-aminophenyl)acrylamide were synthesized and their antiproliferative activities were evaluated against three human cancer cell lines (H1975, PC-3, MGC-803) by using methyl thiazolyl tetrazolium (MTT) assay. The results showed that most compounds exhibited better antiproliferative activities against the four human tumor cell lines. Among them, N-(3-(2-((4-((4-chlorophenyl)amino)-7-methoxy-quinazolin-6-yl)oxy)acetamido)phenyl)acrylamide (13j) showed the best antiproliferative activity against H1975 and MGC-803 cancer cell lines with IC50 values of (6.77±0.65) and (4.06±0.34) μmol/L, respectively. Its activity was better than the positive control gefitinib. In a nutshell, this work provides clues to discover antitumor agent based on the quinazoline scaffold.

Key words: acrylamide, quinazoline, synthesis, antiproliferative activity